According to the latest market report published by Persistence Market Research titled ‘Home Infusion Therapy Devices Market: Global Industry Analysis (2012-2016) and Forecast (2017-2025),’ the global Home Infusion Therapy Devices market is expected to expand at a CAGR of 6.8% during the forecast period 2017–2025. Persistence Market Research delivers key insights and presents a revised forecast of the global Home Infusion Therapy Devices market for an eight year period from 2017 to 2025. The revision in the market size and forecasts have been carried out taking into account the impact of various macroeconomic indicators and other industry based demand driving factors, as well as the recent developments of key market participants. The global home infusion therapy devices market is projected to expand at a healthy CAGR of 6.8% in terms of value during the forecast period, revised from the previous CAGR of 5.5%, due to factors regarding which PMR offers useful insights in detail in this report.
- The Home Infusion Therapy Devices market is segmented based on product type, application, end user and region. On the basis of product type, the market is segmented into disposable elastomeric pumps, insulin pumps, PCA pumps, electronic ambulatory pumps and infusion system pumps accessories. Disposable elastomeric pumps have the highest demand, owing to the higher response rate in home infusion therapy.
- Based on application the market is segmented as enteral nutrition, parenteral nutrition, chemotherapy, antibiotic administration and others. Parenteral nutrition segment is slated to record the highest demand, owing to the higher response rate in home infusion therapy.
- Based on end user the market is segmented into home care setting and long term care centers. Home care setting is said to hold major market share and register a CAGR of 7.6% in terms of value over the forecast period owing to the increasing availability.
- On the basis of region, the market has been segmented into North America, Latin America, Europe, Asia Pacific, and the MEA. North America region dominated the global home infusion therapy devices market, which held around 34.7% of the global market in 2016 and is expected to continue to dominate the overall market partly due to higher awareness and entry of key players into the market by launching different products.
Companies are focusing on collaborations to develop new and more effective products. The product type segment of the home infusion therapy devices market will be boosted by its higher response rate and increasing investments in R&D leading to inorganic growth. The global home infusion therapy devices is highly fragmented owing to the presence of various companies such as B. Braun Melsungen AG., Becton, Dickinson and Company, Johnson & Johnson Private Limited (Animas Corporation), Fresenius Kabi AG, Terumo Corporation, F. Hoffmann-La Roche AG, Smith & Nephew, Pfizer Inc., Baxter International Inc. and Micrel Medical Devices S.A.
For more insights on the global home infusion therapy devices market, write in to Persistence Market Research analysts at firstname.lastname@example.org